Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Brofaromine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Brofaromine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Brofaromine. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Brofaromine. |
| Magnesium sulfate | The therapeutic efficacy of Brofaromine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Brofaromine may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Brofaromine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Brofaromine. |
| Orphenadrine | Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Brofaromine. |
| Pramipexole | Brofaromine may increase the sedative activities of Pramipexole. |
| Ropinirole | Brofaromine may increase the sedative activities of Ropinirole. |
| Rotigotine | Brofaromine may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Brofaromine. |
| Sodium oxybate | Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Thalidomide | Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Apraclonidine | Brofaromine may increase the alpha-adrenergic activities of Apraclonidine. |
| Atomoxetine | The risk or severity of adverse effects can be increased when Brofaromine is combined with Atomoxetine. |
| Betahistine | The metabolism of Betahistine can be decreased when combined with Brofaromine. |
| Bezafibrate | Brofaromine may increase the hepatotoxic activities of Bezafibrate. |
| Buprenorphine | Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Bupropion | The risk or severity of adverse effects can be increased when Brofaromine is combined with Bupropion. |
| Buspirone | The risk or severity of hypertension can be increased when Brofaromine is combined with Buspirone. |
| Carbamazepine | The risk or severity of adverse effects can be increased when Carbamazepine is combined with Brofaromine. |
| Cyclobenzaprine | Cyclobenzaprine may increase the serotonergic activities of Brofaromine. |
| Cyproheptadine | Brofaromine may increase the anticholinergic activities of Cyproheptadine. |
| Dextromethorphan | The risk or severity of serotonin syndrome can be increased when Brofaromine is combined with Dextromethorphan. |
| Diethylpropion | The risk or severity of adverse effects can be increased when Brofaromine is combined with Diethylpropion. |
| Domperidone | The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Brofaromine is combined with Domperidone. |
| Hydrocodone | Brofaromine may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydromorphone | Brofaromine may increase the serotonergic activities of Hydromorphone. |
| Isometheptene | Brofaromine may increase the sympathomimetic activities of Isometheptene. |
| Levonordefrin | Brofaromine may increase the hypertensive activities of Levonordefrin. |
| Lithium citrate | The risk or severity of serotonin syndrome can be increased when Brofaromine is combined with Lithium citrate. |
| Lithium carbonate | The risk or severity of serotonin syndrome can be increased when Brofaromine is combined with Lithium carbonate. |
| Lithium hydroxide | The risk or severity of serotonin syndrome can be increased when Brofaromine is combined with Lithium hydroxide. |
| Maprotiline | The risk or severity of adverse effects can be increased when Brofaromine is combined with Maprotiline. |
| Mianserin | The risk or severity of adverse effects can be increased when Brofaromine is combined with Mianserin. |
| Esmirtazapine | The risk or severity of adverse effects can be increased when Brofaromine is combined with Esmirtazapine. |
| Setiptiline | The risk or severity of adverse effects can be increased when Brofaromine is combined with Setiptiline. |
| Aptazapine | The risk or severity of adverse effects can be increased when Brofaromine is combined with Aptazapine. |
| Mequitazine | Brofaromine may increase the anticholinergic activities of Mequitazine. |
| Methadone | The risk or severity of serotonin syndrome can be increased when Brofaromine is combined with Methadone. |
| Methyldopa | Brofaromine may decrease the hypotensive activities of Methyldopa. |
| Methylphenidate | Brofaromine may increase the hypertensive activities of Methylphenidate. |
| Dexmethylphenidate | Brofaromine may increase the hypertensive activities of Dexmethylphenidate. |
| Oxycodone | Brofaromine may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone. |
| Oxymorphone | The risk or severity of adverse effects can be increased when Oxymorphone is combined with Brofaromine. |
| Pizotifen | Brofaromine may increase the anticholinergic activities of Pizotifen. |
| Reserpine | The risk or severity of adverse effects can be increased when Brofaromine is combined with Reserpine. |
| Tapentadol | The risk or severity of serotonin syndrome can be increased when Brofaromine is combined with Tapentadol. |
| Tetrabenazine | The risk or severity of adverse effects can be increased when Brofaromine is combined with Tetrabenazine. |
| Tramadol | The risk or severity of serotonin syndrome and seizure can be increased when Brofaromine is combined with Tramadol. |
| Trazodone | Brofaromine may increase the serotonergic activities of Trazodone. |
| Altretamine | Altretamine may increase the orthostatic hypotensive activities of Brofaromine. |
| Clemastine | Brofaromine may increase the anticholinergic activities of Clemastine. |
| Doxapram | Brofaromine may increase the hypertensive activities of Doxapram. |
| Linezolid | The risk or severity of serotonin syndrome can be increased when Brofaromine is combined with Linezolid. |
| Norepinephrine | Brofaromine may increase the hypertensive activities of Norepinephrine. |
| Mirtazapine | Brofaromine may increase the serotonergic activities of Mirtazapine. |
| Meperidine | The risk or severity of serotonin syndrome and opioid toxicity can be increased when Brofaromine is combined with Meperidine. |
| Tryptophan | The risk or severity of serotonin syndrome and hypomania can be increased when Tryptophan is combined with Brofaromine. |
| Ethanol | Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Methylene blue | Brofaromine may increase the serotonergic activities of Methylene blue. |
| Atropine | The risk or severity of hypertension can be increased when Brofaromine is combined with Atropine. |
| Brimonidine | The metabolism of Brimonidine can be decreased when combined with Brofaromine. |
| Morphine | Brofaromine may increase the analgesic activities of Morphine. |
| Pholcodine | Pholcodine may increase the serotonergic activities of Brofaromine. |
| Tetryzoline | The risk or severity of hypertension can be increased when Brofaromine is combined with Tetryzoline. |
| Tianeptine | The risk or severity of adverse effects can be increased when Tianeptine is combined with Brofaromine. |
| Valsartan | Brofaromine may increase the hypotensive activities of Valsartan. |
| Ramipril | Brofaromine may increase the hypotensive activities of Ramipril. |
| Esmolol | Brofaromine may increase the hypotensive activities of Esmolol. |
| Betaxolol | Brofaromine may increase the hypotensive activities of Betaxolol. |
| Remikiren | Brofaromine may increase the hypotensive activities of Remikiren. |
| Torasemide | Brofaromine may increase the hypotensive activities of Torasemide. |
| Bethanidine | Brofaromine may increase the hypotensive activities of Bethanidine. |
| Guanadrel | Brofaromine may increase the hypotensive activities of Guanadrel. |
| Metoprolol | Brofaromine may increase the hypotensive activities of Metoprolol. |
| Isradipine | Brofaromine may increase the hypotensive activities of Isradipine. |
| Olmesartan | Brofaromine may increase the hypotensive activities of Olmesartan. |
| Chlorthalidone | Brofaromine may increase the hypotensive activities of Chlorthalidone. |
| Nitroprusside | Brofaromine may increase the hypotensive activities of Nitroprusside. |
| Atenolol | Brofaromine may increase the hypotensive activities of Atenolol. |
| Diltiazem | Brofaromine may increase the hypotensive activities of Diltiazem. |
| Minoxidil | Brofaromine may increase the hypotensive activities of Minoxidil. |
| Timolol | Brofaromine may increase the hypotensive activities of Timolol. |
| Treprostinil | Brofaromine may increase the hypotensive activities of Treprostinil. |
| Amlodipine | Brofaromine may increase the hypotensive activities of Amlodipine. |
| Nimodipine | Brofaromine may increase the hypotensive activities of Nimodipine. |
| Nisoldipine | Brofaromine may increase the hypotensive activities of Nisoldipine. |
| Bendroflumethiazide | Brofaromine may increase the hypotensive activities of Bendroflumethiazide. |
| Prazosin | Brofaromine may increase the hypotensive activities of Prazosin. |
| Fosinopril | Brofaromine may increase the hypotensive activities of Fosinopril. |
| Trandolapril | Brofaromine may increase the hypotensive activities of Trandolapril. |